Business Segments · Depreciation
Diagnostic Products — Depreciation
Abbott Diagnostic Products — Depreciation increased by 5.9% to $144.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.3%, from $126.00M to $144.00M. Over 4 years (FY 2021 to FY 2025), Diagnostic Products — Depreciation shows a downward trend with a -8.5% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026
How to read this metric
Changes reflect the age and scale of the segment's capital infrastructure and investment cycle.
Detailed definition
The systematic allocation of the cost of tangible assets, such as manufacturing equipment and diagnostic instruments, ov...
Peer comparison
Standard accounting metric for capital-intensive businesses.
Metric ID:
abt_segment_diagnostic_products_depreciationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 190M | 190M | 190M | 123.5M | 123.5M | 123.5M | 123.5M | 124.8M | 124.8M | 124.8M | 124.8M | 129M | 129M | 129M | 134M | 126M | 135M | 136M | 136M | 144M |
| QoQ Change | — | +0.0% | +0.0% | -35.0% | +0.0% | +0.0% | +0.0% | +1.0% | +0.0% | +0.0% | +0.0% | +3.4% | +0.0% | +0.0% | +3.9% | -6.0% | +7.1% | +0.7% | +0.0% | +5.9% |
| YoY Change | — | — | — | — | -35.0% | -35.0% | -35.0% | +1.0% | +1.0% | +1.0% | +1.0% | +3.4% | +3.4% | +3.4% | +7.4% | -2.3% | +4.7% | +5.4% | +1.5% | +14.3% |
Range123.5M – 190M
CAGR-5.7%
Avg YoY Growth-3.7%
Median YoY Growth+1.3%
Current Streak4 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Abbott's diagnostic products — depreciation?
- Abbott (ABT) reported diagnostic products — depreciation of $144.00M in Q1 2026.
- How has Abbott's diagnostic products — depreciation changed year-over-year?
- Abbott's diagnostic products — depreciation increased by 14.3% year-over-year, from $126.00M to $144.00M.
- What is the long-term trend for Abbott's diagnostic products — depreciation?
- Over 4 years (2021 to 2025), Abbott's diagnostic products — depreciation has grown at a -8.5% compound annual growth rate (CAGR), from $760.00M to $533.00M.
- What does diagnostic products — depreciation mean?
- The annual non-cash cost of using up physical assets like machinery.